Gain Therapeutics, Inc. (GANX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.9
Day's range
$3.07

Gain Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MARSHALL WACE, LLP 05/15/2026 1.77 M $3.43 M   6.47% 5.37%
POTOMAC CAPITAL MANAGEMENT, INC. 05/14/2026 1.01 M $1.96 M   -0.14% 3.06%
JONES FINANCIAL COMPANIES LLLP 05/15/2026 631.62 K $1.16 M   -10.05% 1.92%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 04/30/2026 568.65 K $1.10 M   0.00% 1.72%
DME CAPITAL MANAGEMENT, LP 05/15/2026 566.13 K $1.10 M   0.00% 1.72%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 447.34 K $868.53 K   12.41% 1.36%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 431.27 K $836.66 K   -36.98% 1.31%
05/15/2026 399.89 K $775.78 K   100.00% 1.21%
GSA CAPITAL PARTNERS LLP 05/08/2026 312.47 K $606.00 K   1,426.31% 0.95%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 229.98 K $446.16 K   100.00% 0.70%
BLACKROCK, INC. 05/13/2026 225.05 K $436.59 K   7.38% 0.68%
UBS GROUP AG 05/05/2026 220.49 K $427.75 K   171.80% 0.67%
JANE STREET GROUP, LLC 05/12/2026 216.88 K $420.75 K   -10.50% 0.66%
CRESSET ASSET MANAGEMENT, LLC 05/15/2026 160.00 K $310.40 K   0.00% 0.49%
STATE STREET CORP 05/15/2026 157.54 K $305.62 K   0.00% 0.48%
MORGAN STANLEY 05/15/2026 139.65 K $270.93 K   -5.38% 0.42%
STRATOS WEALTH PARTNERS, LTD. 04/28/2026 131.62 K $255.35 K   100.00% 0.40%
NORTHERN TRUST CORP 05/14/2026 114.00 K $221.15 K   11.76% 0.35%
LPL FINANCIAL LLC 05/06/2026 104.25 K $202.25 K   -2.16% 0.32%
JANE STREET GROUP, LLC 05/12/2026 38.60 K $74.88 K   100.00% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 38.30 K $74.30 K   25.16% 0.12%
PRELUDE CAPITAL MANAGEMENT, LLC 05/15/2026 35.82 K $69.49 K   0.00% 0.11%
CITADEL ADVISORS LLC 05/15/2026 31.40 K $60.92 K   20.31% 0.10%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 30.00 K $58.21 K   0.00% 0.09%
COMMONWEALTH EQUITY SERVICES, LLC 04/27/2026 29.70 K $57.62 K   134.16% 0.09%
APOLLON WEALTH MANAGEMENT, LLC 04/22/2026 26.50 K $51.41 K   33.67% 0.08%
CITADEL ADVISORS LLC 05/15/2026 24.90 K $48.31 K   100.00% 0.08%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2026 24.50 K $47.53 K   100.00% 0.07%
OLIVER LUXXE ASSETS LLC 04/08/2026 20.25 K $39.29 K   0.00% 0.06%
VANGUARD GLOBAL ADVISERS, LLC 05/08/2026 18.38 K $35.65 K   100.00% 0.06%
WEALTHSPIRE ADVISORS, LLC 05/01/2026 16.90 K $32.79 K   0.00% 0.05%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 04/08/2026 15.56 K $28.78 K   0.00% 0.05%
BENEDICT FINANCIAL ADVISORS INC 04/20/2026 15.50 K $30.07 K   -59.21% 0.05%
SANDHILL CAPITAL PARTNERS LLC 05/14/2026 15.40 K $29.88 K   0.00% 0.05%
MILLINGTON FINANCIAL ADVISORS, LLC 05/08/2026 15.00 K $29.25 K   100.00% 0.05%
CITADEL ADVISORS LLC 05/15/2026 14.50 K $28.13 K   -71.79% 0.04%
SIMPLEX TRADING, LLC 05/14/2026 13.44 K $26.07 K   -71.97% 0.04%
KESTRA ADVISORY SERVICES, LLC 04/30/2026 12.00 K $23.28 K   0.00% 0.04%
WELLS FARGO & COMPANY/MN 05/11/2026 11.05 K $21.44 K   316.98% 0.03%
VIRTU FINANCIAL LLC 05/14/2026 10.69 K $21.00 K   100.00% 0.03%
NEWEDGE ADVISORS, LLC 06/03/2026 10.60 K $20.56 K   0.00% 0.03%
GROUP ONE TRADING, L.P. 05/13/2026 6.40 K $12.42 K   -88.18% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 5.51 K $10.68 K   -19.73% 0.02%
JPMORGAN CHASE & CO 05/13/2026 1.70 K $3.06 K   100.00% 0.01%
LARSON FINANCIAL GROUP LLC 05/15/2026 10 $19   0.00% 0.00%
CITIGROUP INC 05/11/2026 1 $2   100.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/18/2026 0 $0   -100.00% 0.00%
GOLDMAN SACHS GROUP INC 05/15/2026 0 $0   -100.00% 0.00%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 0 $0   -100.00% 0.00%
MAI CAPITAL MANAGEMENT 05/15/2026 0 $0   -100.00% 0.00%

Gain Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 60 institutional investors and hedge funds held shares of Gain Therapeutics Inc. The most heavily invested institutionals were:

MARSHALL WACE, LLP: 1.77 M

Potomac Capital Management, Inc.: 1.01 M

JONES FINANCIAL COMPANIES LLLP: 631,615

Cambridge Investment Research Advisors, Inc.: 568,645

DME Capital Management, LP: 566,130

GEODE CAPITAL MANAGEMENT, LLC: 447,342

24.86% of Gain Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 9.16 M shares in the last 24 months. This purchase volume represents approximately $26.84 M in transactions.